Top Insights
Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.
Related Articles
Dramatic Surge in Bitcoin Millionaires Pushes Bitcoin Hyper to Nearly $18M
Recent data shows that the number of Bitcoin millionaires is climbing at...
Top features to look for in a crypto-trading broker: From fees to user experience
Choosing the right crypto-trading broker impacts profitability, security, and user experience, influencing...
Canton Network taps Chainlink as super validator, integrates oracles and CCIP
Chainlink has integrated its data services and crosschain protocol into the institutional...
Japan’s policy shifts helped it double crypto adoption: Chainalysis
Chainalysis APAC policy lead Chengyi Ong says favorable policy and taxes helped...
Leave a comment